{
    "nctId": "NCT01156168",
    "briefTitle": "Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab",
    "officialTitle": "VEGF Gene Amplification/Deletion and Haplotype as Biomarkers for Bevacizumab in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 363,
    "primaryOutcomeMeasure": "Comparison between VEGF haplotype and median overall survival (OS) and grade 3/4 hypertension (HTN)",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Enrolled on ECOG-E2100\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}